Implications for the assay and biological activity of interleukin-4. Results of a WHO international collaborative study.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  JIM - Journal of Immunological Methods

• Publication date

  1996-07-17

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0022-1759(96)00157-3PMID 8690937
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interleukin-8 expression by head and neck squamous cell carcinoma.

  1995cited by this paper
• IL‐8/IL‐8 receptor expression in psoriasis and the response to systemic tacrolimus (FK506) therapy

  1995cited by this paper
• Inactivation of interleukin‐8 by aminopeptidase N (CD13)

  1995cited by this paper
• Synthetic hexa- and heptapeptides that inhibit IL-8 from binding to and activating human blood neutrophils.

  1995cited by this paper
• Interleukin‐6 and interleukin‐8 concentrations as predictors of outcome in ventricular assist device patients before heart transplantation

  1994cited by this paper
• Selective enhancement of GM-CSF, TNF-alpha, IL-1 beta and IL-8 production by monocytes and macrophages of asthmatic subjects.

  1994cited by this paper
• Interleukin-8 in chronic renal failure and dialysis patients.

  1994cited by this paper
• Detection of urinary interleukin-8 in glomerular diseases.

  1994cited by this paper
• Correlation of Serum Interleukin-8 and Cell Surface Lysosome-associated Membrane Protein with Clinical Disease Activity in Systemic Lupus Erythematosus

  1994cited by this paper
• Pentoxifylline in vivo down-regulates the release of IL-1 beta, IL-6, IL-8 and tumour necrosis factor-alpha by human peripheral blood mononuclear cells.

  1994cited by this paper
• The Role of Interleukin‐8 in the Infectious Process a

  1994cited by this paper
• Detection of plasma interleukin-8 in atopic dermatitis.

  1994cited by this paper
• Interleukin-8 antitumour effect is associated with a local infiltration but not with a systemic activation of T lymphocytes.

  1994cited by this paper
• Effect of recombinant human interleukin‐3 on haematological recovery from chemotherapy‐induced myelosuppression

  1994cited by this paper
• Essential involvement of interleukin‐8 (IL‐8) in acute inflammation

  1994cited by this paper
• Phase II studies of recombinant human interleukin-4 in advanced renal cancer and malignant melanoma.

  1994cited by this paper
• Interleukin-8: a review.

  1993cited by this paper
• ETH615, a synthetic inhibitor of leukotriene biosynthesis and function, also inhibits the production of and biological responses towards interleukin‐8

  1993cited by this paper
• IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor.

  1993cited by this paper
• Glycosylation does not affect in-vitro biological activity of interleukin-3.

  1993cited by this paper
• Recombinant human interleukin-4 inhibits growth of some human lung tumor cell lines in vitro and in vivo.

  1993cited by this paper
• Level of neutrophil chemotactic factor CINC/gro, a member of the interleukin-8 family, associated with lipopolysaccharide-induced inflammation in rats

  1992cited by this paper
• Antiproliferative effects of interleukin-4 on freshly isolated non-Hodgkin malignant B-lymphoma cells.

  1992cited by this paper
• Recombinant human interleukin 4 (IL-4) given as daily subcutaneous injections--a phase I dose toxicity trial.

  1992cited by this paper
• Development and application of a radioimmunoassay for interleukin-8: detection of interleukin-8 in synovial fluids from patients with inflammatory joint disease.

  1992cited by this paper
• Flow cytometric evaluation of the effects of leukotriene B4 receptor antagonists (LY255283 and SC-41930) on calcium mobilization and integrin expression of activated human neutrophils.

  1992cited by this paper
• Effects of recombinant human interleukin-3 in patients with relapsed small-cell lung cancer treated with chemotherapy: a dose-finding study.

  1992cited by this paper
• Inhibition of colon and breast carcinoma cell growth by interleukin-4.

  1992influential reference
• Production of neutrophil activating peptide-1 (NAP-1/IL-8) by blood and synovial fluid mononuclear cells from patients with arthritis.

  1992cited by this paper
• In vivo priming of platelet-activating factor-induced eosinophil chemotaxis in allergic asthmatic individuals

  1992cited by this paper
• Properties of the novel proinflammatory supergene "intercrine" cytokine family.

  1991cited by this paper
• Modulation and induction of eosinophil chemotaxis by granulocyte- macrophage colony-stimulating factor and interleukin-3

  1991cited by this paper
• Rat CINC, a member of the interleukin-8 family, is a neutrophil-specific chemoattractant in vivo.

  1991cited by this paper
• Interleukin 8 (NAP-1) and related chemotactic cytokines

  1991cited by this paper
• Presence of NAP‐1/IL‐8 in Synovial Fluids Indicates a Possible Pathogenic Role in Rheumatoid Arthritis

  1991cited by this paper
• Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin 8

  1991cited by this paper
• Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4.

  1991influential reference
• Purification and characterization of natural human interleukin-3.

  1991cited by this paper
• Kinetics of TNF, IL-6, and IL-8 gene expression in LPS-stimulated human whole blood.

  1991cited by this paper
• Interleukin 8-inhibitor and inducer of histamine and leukotriene release in human basophils.

  1991cited by this paper
• Neutrophil-activating peptide 1/interleukin 8 mRNA expression and protein secretion by human monocytes: effect of cyclosporin A.

  1991cited by this paper
• Effects of recombinant human interleukin-3 in patients with myelodysplastic syndromes.

  1990cited by this paper
• Leukocyte specificity and binding of human neutrophil attractant/activation protein-1.

  1990cited by this paper
• A bioassay for the measurement of human interleukin-4.

  1990cited by this paper
• Functional activation of human neutrophils by recombinant monocyte-derived neutrophil chemotactic factor/IL-8.

  1990cited by this paper
• Effects of recombinant human interleukin-3 in aplastic anemia.

  1990cited by this paper
• The neutrophil‐activating proteins interleukin 8 and β‐thromboglobulin: in vitro and in vivo comparison of NH2‐terminally processed forms

  1990cited by this paper
• A new simplified single-filter assay for 'in vitro' evaluation of chemotaxis of 51Cr-labeled polymorphonuclear leukocytes.

  1989cited by this paper
• Purification and characterization of cytokine-induced neutrophil chemoattractant produced by epithelioid cell line of normal rat kidney (NRK-52E cell).

  1989cited by this paper
• Influence of botulinum C2 toxin on F-actin and N-formyl peptide receptor dynamics in human neutrophils

  1989cited by this paper
• Human granulocyte chemotactic peptide (IL-8) as a specific neutrophil degranulator: comparison with other monokines.

  1989cited by this paper
• Interleukin-4: molecular structure and biochemical characteristics, biological function, and receptor expression.

  1989cited by this paper
• The neutrophil chemoattractant produced by the rat kidney epithelioid cell line NRK-52E is a protein related to the KC/gro protein.

  1989cited by this paper
• Production and characterization of monoclonal antibodies against the novel neutrophil activating peptide NAP/IL-8.

  1989cited by this paper
• The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes.

  1989cited by this paper
• Establishment and characterization of a unique human cell line that proliferates dependently on GM‐CSF, IL‐3, or erythropoietin

  1989cited by this paper
• The neutrophil-activating peptide NAF/NAP-1 induces histamine and leukotriene release by interleukin 3-primed basophils

  1989cited by this paper
• Granulocyte chemotactic protein/interleukin-8 induces plasma leakage and neutrophil accumulation in rabbit skin.

  1989cited by this paper
• Synthesis and expression in Escherichia coli of the gene encoding monocyte-derived neutrophil-activating factor: biological equivalence between natural and recombinant neutrophil-activating factor.

  1988cited by this paper
• Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor

  1988cited by this paper
• Molecular Biology of Interleukin 4 and Interleukin 5 Genes and Biology of their Products that Stimulate B Cells, T Cells and Hemopoietic Cells

  1988cited by this paper
• [2] Visual methods for measuring leukocyte locomotion

  1988cited by this paper
• Selective growth response to IL‐3 of a human leukaemic cell line with megakaryoblastic features

  1988cited by this paper
• Interleukin 3 : the panspecific hemopoietin

  1988cited by this paper
• The use of fura-2 to determine the relationship between cytoplasmic free Ca2+ and oxidase activation in rat neutrophils.

  1988cited by this paper
• A novel neutrophil-activating factor produced by human mononuclear phagocytes

  1988cited by this paper
• Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity.

  1987cited by this paper
• Purification and amino acid sequencing of NAF, a novel neutrophil-activating factor produced by monocytes.

  1987cited by this paper
• Lucigenin chemiluminescence in the assessment of neutrophil superoxide production.

  1987cited by this paper
• Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL 1).

  1987cited by this paper
• High-efficiency purification and chemical characterization of B cell stimulatory factor-1/interleukin 4.

  1987cited by this paper
• Tumor necrosis factor is chemotactic for monocytes and polymorphonuclear leukocytes.

  1987cited by this paper
• Characterization of a human multilineage-colony-stimulating factor cDNA clone identified by a conserved noncoding sequence in mouse interleukin-3.

  1987cited by this paper
• Evaluation of PAF antagonists using human neutrophils in a microtiter plate assay.

  1987cited by this paper
• Human IL-3 (multi-CSF): identification by expression cloning of a novel hematopoietic growth factor related to murine IL-3.

  1986cited by this paper
• Isolation and characterization of a human interleukin cDNA clone, homologous to mouse B-cell stimulatory factor 1, that expresses B-cell- and T-cell-stimulating activities.

  1986cited by this paper
• The locomotor capacity of human lymphocytes and its enhancement by cell growth.

  1986cited by this paper
• Novel neutrophil chemotactic factor derived from human peripheral blood mononuclear leucocytes.

  1986cited by this paper
• Neutrophil leucocyte chemotaxis: a simplified assay for measuring polarizing responses to chemotactic factors.

  1985cited by this paper
• Molecular cloning of cDNA for murine interleukin-3

  1984cited by this paper
• Biologic properties of homogeneous interleukin 3. I. Demonstration of WEHI-3 growth factor activity, mast cell growth factor activity, p cell-stimulating factor activity, colony-stimulating factor activity, and histamine-producing cell-stimulating factor activity.

  1983cited by this paper
• Procedures for the purification of interleukin 3 to homogeneity.

  1982cited by this paper
• Release of gelatinase from a novel secretory compartment of human neutrophils.

  1982cited by this paper
• Identification of a T cell-derived b cell growth factor distinct from interleukin 2

  1982cited by this paper
• THE CHEMOTACTIC EFFECT OF MIXTURES OF ANTIBODY AND ANTIGEN ON POLYMORPHONUCLEAR LEUCOCYTES

  1962cited by this paper

• Cytokines as Biomarkers in Rheumatoid Arthritis

  2014cites this paper
• Advances and prospects of anginex as a promising anti-angiogenesis and anti-tumor agent.

  2012cites this paper
• Reconstituting National Institute for Biological Standards and Control (NIBSC) chemokines.

  2012cites this paper
• HEMATOPOIETIC GROWTH FACTORS AS BIOPHARMACEUTICALS: AN OVERVIEW

  2012cites this paper
• Biomarkers of Cardiovascular Disease: Molecular Basis and Practical Considerations

  2006cites this paper
• CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice Laboratory Tests Available to Assess Inflammation— Performance and Standardization A Background Paper

  2004cites this paper
• Evaluation of Accuracy and Uncertainty of ELISA Assays for the Determination of Interleukin-4, Interleukin-5, Interferon-γ and Tumor Necrosis Factor-α

  2002cites this paper
• Evaluation of accuracy and uncertainty of ELISA assays for the determination of interleukin-4, interleukin-5, interferon-gamma and tumor necrosis factor-alpha.

  2002cites this paper
• Anginex, a designed peptide that inhibits angiogenesis.

  2001cites this paper
• Measurement of Cytokines in Synovial Fluid

  2001cites this paper
• Measurement of Cytokines in Clinical Samples Using Immunoassays: Problems and Pitfalls

  2000cites this paper
• Need for an External Proficiency Testing Program for Cytokines, Chemokines, and Plasma Markers of Immune Activation

  2000cites this paper
• Plasma cytokines: what we are measuring.

  1999cites this paper
• Interleukin-8 plays its role at local level in psoriasis vulgaris.

  1999cites this paper
• Stability of plasma levels of cytokines and soluble activation markers in patients with human immunodeficiency virus infection.

  1999cites this paper
• Variables That Affect Assays for Plasma Cytokines and Soluble Activation Markers

  1999cites this paper
• Levels of Cytokines and Immune Activation Markers in Plasma in Human Immunodeficiency Virus Infection: Quality Control Procedures

  1998cites this paper
• WHO cytokine standardization: facilitating the development of cytokines in research, diagnosis and as therapeutic agents.

  1998cites this paper
• Human IP-10 selectively promotes dominance of polyclonally activated and environmental antigen-driven IFN-gamma over IL-4 responses.

  1998cites this paper
• Developments in immunological standardization.

  1998cites this paper
• Human IP‐10 selectively promotes dominance of polyclonally activated and environmental antigen‐driven IFN‐γ over IL‐4 responses

  1998cites this paper
• Human Ip-10 Selectively Promotes Dominance of Polyclonally Activated and Environmental Antigen- Driven Ifn-g over Il-4 Responses Human Ip-10 Selectively Promotes Dominance of Polyclonally Activated and Environmental Antigen- Driven Ifn-g over Il-4 Responses. Faseb

  year unknowncites this paper